Lovelace Biomedical


Lovelace Biomedical is a not-for-profit preclinical contract research organization dedicated to advancing biomedical science through nonclinical and clinical research focused on toxicology, drug development, infectious diseases, and more. With a history spanning nearly seven decades, it emphasizes personalized service, scientific excellence, and innovative technologies. The organization has played a significant role in responding to COVID-19 by developing therapeutics and animal models to fight the virus. It is committed to humane animal care, environmental enrichment, and supporting research that improves health and well-being.

Industries

biotechnology
non-profit
pharmaceutical

Nr. of Employees

large (251-1000)

Lovelace Biomedical

2425 Ridgecrest Dr. SE, Albuquerque, NM 87108-5127


Products

Preclinical Research

Conducts research prior to clinical trials to evaluate drug efficacy and safety.

Toxicology

Analyzes and understands the effects of toxic chemical substances on biological systems.

Inhalation Drug Delivery

Develops and tests methods for delivering drugs via inhalation, particularly for respiratory diseases.

Gene Therapy Development

Researches and develops gene therapies for various diseases, including cystic fibrosis and certain cancers.

Animal Housing

Provides extensive facilities for housing various animal species used in preclinical research.

Analytical and Bioanalytical Chemistry

Develops precise formulations and assays to quantify drug distribution and metabolism.


Services

Method development, method validation, sample analysis, metabolite identification, biomarker analysis and PK/TK support across multiple analytical platforms.

Design and conduct of GLP toxicology and pharmacology studies, including IND/NDA-enabling programs and safety assessments in multiple species.

Aerosol exposure testing, inhaler and nebulizer characterization, regional deposition studies and inhalation delivery development for pulmonary and systemic therapeutics.

Efficacy, biodistribution, immunogenicity and toxicology studies tailored to gene therapy products, with support for pre‑IND interactions and regulatory submissions.

Multi-species animal housing, surgical suites, colony management and logistical support for long-term and large-scale preclinical programs.

Onsite microbiology and virology laboratory testing integrated with high-containment studies to support infectious disease research and medical countermeasure evaluation.

View All Services

Expertise Areas

  • Preclinical GLP toxicology
  • Bioanalytical chemistry and regulated method validation
  • Pharmacokinetics / toxicokinetics and PK/PD modeling
  • Inhalation and aerosol drug-delivery development
  • Show More (10)

Key Technologies

  • Liquid chromatography–tandem mass spectrometry (LC-MS/MS)
  • Immunoassays (ELISA, electrochemiluminescence)
  • qPCR / RT‑PCR
  • Flow cytometry
  • Show More (9)

News & Updates

Research on RSV and therapeutics development.

Research on aerosol science and mask performance related to COVID-19.

Discussion on the use of animals in non-clinical research.

Recognition for high impact research in aerosol science and mask performance.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.